Individualized Medication Guidance for Cancer (800 Genes)

Minimum Order: 1

Packaging: N/A

Delivery: 15 Days

This test detects 800 genes related to targeted therapy, chemotherapy and endocrine drug, hereditary tumor, immunotherapy-related information (MSI and TMB), tumor core signaling pathway and tumor prognosis. The types of variants detected include SNV, InDel, amplifications and gene fusions, helping doctors formulate professional and individualized treatment plans for patients.

Features of Individualized Medication Guidance for Cancer (800 Genes)

Applicable Population of Individualized Medication Guidance for Cancer (800 Genes)

Patients with locally advanced or metastatic tumors looking for targeted drug therapy.

Patients with locally advanced or metastatic solid tumors and expecting immunotherapy, but no definitive driver genes been diagnosed.

Patients with locally advanced or metastatic solid tumors who are undergoing targeted therapy/immunotherapy, expecting dynamic monitoring of treatment through NGS.

Specification of Individualized Medication Guidance for Cancer (800 Genes)

Sample types Fresh tissue + venous blood / Paraffin specimen + venous blood / Venous blood

TAT 10 working days

As one of biotech companies genetic sequencing, we can provide professional genome sequencing service for clients, if you have needs, please contact us.

Country: China (Mainland)
Business Type:
Market:
Founded Year:
Address:Building C, Block 88 Kechuang 6th Street, Yizhuang Biomedical Park, Beijing
Contact:capitalbio technology

Individualized Medication Guidance for Cancer (800 Genes)

more images of Individualized Medication Guidance for Cancer (800 Genes)

*Your name:	Enter name here eg:Ralph zhang
*Your Email:	Enter email here
*To:	CapitalBio Technology Co., Ltd.
*Subject:
*Message:
	Enter between 20 to 3,000 characters. English only. Characters : 0 / 3000
*Enter the secure code shown below	Reload Image

		We do inquire for you , please wait ...

Next Generation Sequencing Platform

Neuromuscular Disorders

Mycobacteria Species Identification

Mycobacteria Nucleic Acid Detection

Karyotype Analysis

Individualized Medication Guidance for Prostate Cancer

This test detects 346 genes, including HRR pathway genes. The content involves targeted therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive medication reference for prostate cancer patients. Features of Individualized Medication ...

CapitalBio Technology Co., Ltd.

Individualized Medication Guidance for Gynecologic Cancer

Gynecologic Cancer Surgery According to the latest Chinese women\'s new cancer statistics, cervical cancer and ovarian cancer are in the top ten new cases of female cancer (about 110,000 and 60,000 respectively). With the widespread clinical use of poly(ADP-ribose) polymerase ...

CapitalBio Technology Co., Ltd.

Individualized Medication Guidance for Gastrointestinal Cancer

This test detects 84 genes related to gastrointestinal cancer, provides information on targeted drug, chemotherapy, and hereditary risk assessment. Features of Individualized Medication Guidance for Gastrointestinal Cancer Treatment Targeted drug Gastrointestinal targeted drug ...

CapitalBio Technology Co., Ltd.

Individualized Medication Guidance for Cancer (800 Genes)

Product Quick Detail

Specifications

CapitalBio Technology Co., Ltd.

Send inquiry / quota request to Individualized Medication Guidance for Cancer (800 Genes)

Other products from CapitalBio Technology Co., Ltd.

Relate products of Individualized Medication Guidance for Cancer (800 Genes)

Social Connect

Ask / Review Mfrbee.com

Contact Us